OncLive® On Air

Hodgkin's Lymphoma

Chemotherapy

Oncology

Colorectal Cancer

Nivolumab

Onc201

Hepatic Artery Infusion

H3K27M Mutant Diffuse Midline Gliomas

Immunotherapy

CAR T-Cell Therapy

ACTION Trial

Her2-Positive Breast Cancer

FDA Approval

Ponatinib

Swog 1826

Siltocaptagine Autolucel

Multiple Myeloma

Colorectal Cancer Management

Malignant Perivascular Epithelioid Cell Tumors

Glioma

In OncLive® On Air, you can expect to hear interviews with academic oncologists on the thought-provoking oncology presentations they give at the OncLive® State of the Science Summits. The topics in oncology vary, from systemic therapies, surgery, radiation therapy, to emerging therapeutic approaches in a particular type of cancer. This includes lung cancer, breast cancer, gastrointestinal cancers,... more

31 ratings

Publishes	Daily	Episodes	500	Founded	8 years ago
Number of Listeners		Categories	ScienceHealth & Fitness

Listen to this Podcast

Guests Host Reviews Talking Points

Latest Episodes

S16 Ep22: Leading Breast Oncologists Share Advice and Optimism for Future Women in Oncology: With Kelly E. McCann, MD, PhD, and Sara Nunnery, MD, MSCI

In today’s episode, we sat down with Kelly E. McCann, MD, PhD, and Sara Nunnery, MD, MSCI, as they shared their stories and perspectives as leading women in oncology in honor of International Women's Day, which is observed annually on March 8. Dr McC... more

8 Mar 2026 • 18 min

S16 Ep21: FDA Approval Insights: SC Daratumumab Plus VRd Provides Additional Treatment Avenue in Transplant-Ineligible, Newly Diagnosed Myeloma: With Saad Z. Usmani, MD, MBA, FACP, FASCO

In today’s episode, we welcomed Saad Z. Usmani, MD, MBA, FACP, FASCO, to discuss the significance of the January 2026 FDA approval of daratumumab and hyaluronidase-fihj (Darzalex Faspro) in combination with bortezomib (Velcade), lenalidomide (Revlimi... more

6 Mar 2026 • 7 min

S16 Ep20: Medical Crossfire®: Breakthroughs in Non–Muscle-Invasive Bladder Cancer: Advancing Patient Care Through Innovation in Treatment

In this podcast, experts Ashish M. Kamat, MD, MBBS, Katie S. Murray, DO, MS, and Thomas Powles, MD, MBBS, MRCP, discuss the classification of BCG responsiveness and intravesical and systemic therapies for non-muscle invasive bladder cancer.

6 Mar 2026 • 30 min

S16 Ep20: Incorporating TROP2-Targeted ADCs Into Lung Cancer Treatment Algorithms: With Eric K. Singhi, MD

In today’s episode, we spoke with Eric K. Singhi, MD. Dr Singhi is an assistant professor in the departments of general oncology and thoracic/head and neck medical oncology at The University of Texas MD Anderson Cancer Center in Houston.

Antibody-dr... more

5 Mar 2026 • 8 min

Key Facts

Accepts Guests

Contact Information

Podcast Host

Number of Listeners

Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Oncology Brothers: Practice-Changing Cancer DiscussionsOncology Brothers

Up First from NPRNPR

Research To Practice | Oncology VideosDr Neil Love

Oncology Today with Dr Neil LoveDr. Neil Love

ASCO Daily NewsAmerican Society of Clinical Oncology (ASCO)

Recent Guests

Megan Kruse

Episode: S16 Ep17: Breast Imaging Advances Emphasize the Importance of Patient-Focused Nuclear Medicine Collaboration: With Megan Kruse, MD; and Sophia O’Brien, MD

Sophia O'Brien

Episode: S16 Ep17: Breast Imaging Advances Emphasize the Importance of Patient-Focused Nuclear Medicine Collaboration: With Megan Kruse, MD; and Sophia O’Brien, MD

Sarah Sammons, MD

Oncologist discussing Pumitamig and its trial results.

Episode: S16 Ep14: Pumitamig Represents Potential Immunotherapy Strategy for TNBC: With Sarah Sammons, MD

Rashmi Chugh

MD specializing in oncology and desmoid tumors

Episode: S16 Ep13: Positive Phase 3 Data Drive Varegacestat Development in Desmoid Tumors: With Rashmi Chugh MD

Quinto Gesiotto

MD and expert in chronic myeloid leukemia treatment

Episode: S16 Ep10: Optimizing TKI Sequencing and Ponatinib Dosing Strategies in CML: With Quinto Gesiotto, MD

Alexander I. Spira

MD, PhD, FACP, FASCO, a leading expert in oncology

Episode: S16 Ep6: FDA Approval Insights: Subcutaneous Amivantamab for EGFR-Mutated NSCLC: With Alexander I. Spira, MD, PhD, FACP, FASCO

Nicholas Short

Associate Professor in the Department of Leukemia at the University of Texas MD Anderson Cancer Center

University of Texas MD Anderson Cancer Center

Episode: S16 Ep4: Comprehensive Ph+ ALL Paradigm Knowledge Informs Frontline Ponatinib Use: With Nicholas Short, MD

Christopher Lieu, MD

Co-director of the Gastrointestinal Medical Oncology Program and professor of medicine in the Department of Medical Oncology at the University of Colorado Cancer Center.

University of Colorado Cancer Center

Episode: S16 Ep3: Third-Line Treatment Selection in mCRC Is Shaped By Recalibration of Patient Priorities and Molecular Retesting: With Christopher Lieu, MD

Andrew Lipsky, MD

Assistant professor of medicine at Columbia University Medical Center

Columbia University Medical Center

Episode: S15 Ep46: Expanded BTK Inhibitor Research Directs the Evolution of Pirtobrutinib Use in CLL: With Andrew Lipsky, MD

Host

Courtney Flaherty

Host of OncLive On Air

Reviews

4.5 out of 5 stars from 31 ratings

Best option for CME podcasts
Love the content! Easily the best platform for listening to CME and staying updated while on the go. Keep up the great work!
Apple Podcasts
5
Dlshaka
United States8 months ago
My favorite podcast for oncology
This podcast provides excellent information to anyone who works in the medical field on oncology.
Apple Podcasts
5
Chiliman1986
United States6 years ago

Embed These Reviews on a Website

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

The show is highly regarded for its focused content on oncology, which is seen as valuable for those in the medical field.

Listeners appreciate the wealth of information provided, particularly highlighting its relevance for continuing medical education and professional growth.

Top Health & Fitness Podcasts

The Dylan Gemelli PodcastDylan Gemelli

Huberman LabScicomm Media

We're Out of TimeRichard Taite

Passion Struck with John R. MilesPassion Struck Network

On Purpose with Jay ShettyiHeartPodcasts

The Dr. John Delony ShowRamsey Network

Tony Mantor: Why Not Me ?Tony Mantor

Nothing much happens: bedtime stories to help you sleepWellness Loud

Decoded | Unlock The Secrets of Human Behavior, Emotion and MotivationBizzie Gold | Mental Health Innovator and Break Method Founder

The School of GreatnessLewis Howes

Talking Points

Recent interactions between the hosts and their guests.

S16 Ep14: Pumitamig Represents Potential Immunotherapy Strategy for TNBC: With Sarah Sammons, MD

Q: What was found regarding the safety of Pumitamig and did outcomes vary based on the chemotherapy backbone used?

The safety profile was manageable with no Pumitamig-related deaths; however, it is too soon to determine efficacy differences based on chemotherapy backbones used.

S16 Ep14: Pumitamig Represents Potential Immunotherapy Strategy for TNBC: With Sarah Sammons, MD

Q: What were the key efficacy data presented from this study thus far?

The study showed a 61.5% confirmed overall objective response rate and a 72% unconfirmed objective response rate among first or second line patients.

S16 Ep14: Pumitamig Represents Potential Immunotherapy Strategy for TNBC: With Sarah Sammons, MD

Q: Can you just provide some background on Pumitamig and the rationale for exploring its use in triple negative breast cancer via PDL-1 and VEGF-A targeting?

Pumitamig is a dual mechanism therapy targeting both PDL-1 and VEGF-A to restore T cell function, normalize tumor vasculature, and enhance immune cell function.

S16 Ep11: Expert Illustrations & Commentaries: Translating the Science of Bispecific Antibodies in Solid Tumors – From Mechanisms to Emerging Data

Q: What do you think is the most effective approach for treating mesothelioma?

Combination therapy with PD-1, CTLA-4 inhibitors, and chemotherapy is expected to provide the best overall survival.

S16 Ep11: Expert Illustrations & Commentaries: Translating the Science of Bispecific Antibodies in Solid Tumors – From Mechanisms to Emerging Data

Q: What are the benefits of combining PD-1 and CTLA-4 inhibitors?

They target different stages of the immune response, offering complementary biology for a more coordinated therapeutic approach.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About OncLive® On Air

What is OncLive® On Air about and what kind of topics does it cover?

Focusing on the latest advancements in oncology, this show offers insights from academic oncologists on cutting-edge research and treatments. Discussions range across various cancer types, including lung, breast, gastrointestinal, hematologic, gynecologic, and genitourinary cancers, reflecting a comprehensive approach to modern cancer care. Unique to this program is its emphasis on both systemic therapies and innovative therapeutic methods, providing listeners with a deep understanding of emerging trends in oncology.

Where can I find podcast stats for OncLive® On Air?

Rephonic provides a wide range of podcast stats for OncLive® On Air. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to OncLive® On Air and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does OncLive® On Air get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for OncLive® On Air, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for OncLive® On Air?

Rephonic provides comprehensive predictive audience data for OncLive® On Air, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does OncLive® On Air have?

To see how many followers or subscribers OncLive® On Air has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to OncLive® On Air?

These podcasts share a similar audience with OncLive® On Air:

1. Oncology Brothers: Practice-Changing Cancer Discussions
2. Up First from NPR
3. Research To Practice | Oncology Videos
4. Oncology Today with Dr Neil Love
5. ASCO Daily News

How many episodes of OncLive® On Air are there?

OncLive® On Air launched 8 years ago and published 500 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact OncLive® On Air?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for OncLive® On Air?

Rephonic pulls ratings and reviews for OncLive® On Air from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for OncLive® On Air?

Rephonic provides full transcripts for episodes of OncLive® On Air. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on OncLive® On Air?

Recent guests on OncLive® On Air include:

1. Megan Kruse
2. Sophia O'Brien
3. Sarah Sammons, MD
4. Rashmi Chugh
5. Quinto Gesiotto
6. Alexander I. Spira
7. Nicholas Short
8. Christopher Lieu, MD

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.

Try it free for 7 days